Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker for Friedreich's Ataxia: An International, Multicenter, Observational, Longitudinal Protocol

NCT04548921 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT04548921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04548921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker for Friedreich's Ataxia: An International, Multicenter, Observational, Longitudinal Protocol
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frda, fxn gene, hereditary diseases